INCB-100658
- Generic Name
- INCB-100658
A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms
- First Posted Date
- 2024-03-15
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Incyte Corporation
- Target Recruit Count
- 144
- Registration Number
- NCT06313593
- Locations
- 🇺🇸
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
🇺🇸Stanford University, Palo Alto, California, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant
Phase 1
Recruiting
- Conditions
- Healthy Participants
- Interventions
- First Posted Date
- 2024-01-19
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- Incyte Corporation
- Target Recruit Count
- 180
- Registration Number
- NCT06213818
- Locations
- 🇦🇺
Nucleus Network Pty Ltd, Melbourne, Victoria, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath